134. Assessment of the Dystrophin Gene Exon 53 Skipping Using DMD Patient-Derived Fibroblasts for Exploratory Clinical Trial of Antisense Drug NS-065/NCNP-01

Molecular Therapy - United States

doi 10.1016/s1525-0016(16)35147-4